BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site
- PMID: 21324100
- PMCID: PMC3107974
- DOI: 10.1111/j.1755-148X.2011.00837.x
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site
Abstract
Oncogenic BRAF mutations are more frequent in cutaneous melanoma occurring at sites with little or moderate sun-induced damage than at sites with severe cumulative solar ultraviolet (UV) damage. We studied cutaneous melanomas from geographic regions with different levels of ambient UV radiation to delineate the relative effects of cumulative UV damage, age, and anatomic site on the frequency of BRAF mutations. We show that BRAF-mutated melanomas occur in a younger age group on skin without marked solar elastosis and less frequently affect the head and neck area, compared to melanomas without BRAF mutations. The findings indicate that BRAF-mutated melanomas arise early in life at low cumulative UV doses, whereas melanomas without BRAF mutations require accumulation of high UV doses over time. The effect of anatomic site on the mutation spectrum further suggests regional differences among cutaneous melanocytes.
© 2011 John Wiley & Sons A/S.
Figures
Similar articles
-
BRAF mutation status in primary and metastatic melanomas in two regions with differing potential ultraviolet radiation exposure.Clin Exp Dermatol. 2014 Dec;39(8):932-43. doi: 10.1111/ced.12430. Epub 2014 Sep 29. Clin Exp Dermatol. 2014. PMID: 25262755
-
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.JAMA Oncol. 2015 Jun;1(3):359-68. doi: 10.1001/jamaoncol.2015.0493. JAMA Oncol. 2015. PMID: 26146664 Free PMC article.
-
Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.Lab Invest. 2017 Feb;97(2):130-145. doi: 10.1038/labinvest.2016.143. Epub 2017 Jan 9. Lab Invest. 2017. PMID: 28067894
-
Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma.J Am Acad Dermatol. 2015 Jun;72(6):1036-46.e2. doi: 10.1016/j.jaad.2015.02.1113. Epub 2015 Mar 25. J Am Acad Dermatol. 2015. PMID: 25819940 Review.
-
BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.J Clin Pathol. 2005 Jun;58(6):640-4. doi: 10.1136/jcp.2004.022509. J Clin Pathol. 2005. PMID: 15917418 Free PMC article. Review.
Cited by
-
Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR.Int J Mol Sci. 2024 Feb 15;25(4):2308. doi: 10.3390/ijms25042308. Int J Mol Sci. 2024. PMID: 38396984 Free PMC article.
-
Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients.Cancers (Basel). 2023 Dec 26;16(1):127. doi: 10.3390/cancers16010127. Cancers (Basel). 2023. PMID: 38201554 Free PMC article.
-
The Genomic Landscape of Melanoma and Its Therapeutic Implications.Genes (Basel). 2023 Apr 29;14(5):1021. doi: 10.3390/genes14051021. Genes (Basel). 2023. PMID: 37239381 Free PMC article. Review.
-
Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective.Front Oncol. 2023 Mar 14;13:1032300. doi: 10.3389/fonc.2023.1032300. eCollection 2023. Front Oncol. 2023. PMID: 36998456 Free PMC article. Review.
-
BRAFV600E mutational status assessment in cutaneous melanocytic neoplasms in a group of the Egyptian population.Cancer Cell Int. 2023 Feb 3;23(1):17. doi: 10.1186/s12935-023-02858-1. Cancer Cell Int. 2023. PMID: 36737739 Free PMC article.
References
-
- Bauer J, Buttner P, Wiecker TS, Luther H, Garbe C. Risk Factors Of Incident Melanocytic Nevi: A Longitudinal Study In A Cohort Of 1,232 Young German Children. International Journal Of Cancer. 2005;115:121–6. - PubMed
-
- Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital Melanocytic Nevi Frequently Harbor Nras Mutations But No Braf Mutations. J Invest Dermatol. 2007;127:179–82. - PubMed
-
- Cooke KR, Fraser J. Migration And Death From Malignant Melanoma. Int J Cancer. 1985;36:175–8. - PubMed
-
- Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic Activation Of Kit In Distinct Subtypes Of Melanoma. J Clin Oncol. 2006;24:4340–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
